跳至主要内容
临床试验/NCT06062004
NCT06062004招募中不适用

Evaluation of Different Lenticule Diameters in Myopic Astigmatism Correction With SMILE Procedures

Al Watany Eye Hospital2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年11月27日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
50
试验地点
2
主要终点
The safety index of using 7 and 6.5 mm lenticule diameters SMILE to treat myopic astigmatism

研究概览

简要总结

Small incision lenticule extraction (SMILE) is a refractive intrastromal procedure for myopia and myopic astigmatism correction. Most of the studies evaluating astigmatic correction by SMILE reported astigmatic under-correction, especially in high degrees of astigmatism.

This under-correction could be due to: first, the active eye tracker or the iris registration is not yet available to overcome the cyclotorsion that occurred during the treatment with the VisuMax femtosecond laser system (Carl Zeiss Meditec, Jena, Germany) which could be overcome by manual compensation technique, especially in higher degrees of cylinders (> 1.5 diopters (D)). Second, in patients with small lenticule diameters, the more abrupt change in thickness at the edge of the treated area could induce more stromal and epithelial healing in this area. Thus, the astigmatic correction would be less effective with small than large lenticule diameters for similar high preoperative astigmatism.

This study assessed the outcome of using a 0.5 millimeter (mm) larger lenticule diameter in the fellow eyes of myopic astigmatic correction SMILE participants. This assessment included the safety and effectiveness indices, the refractive and visual outcomes, the contrast sensitivity, and some morphological outcomes such as corneal curvature and epithelial and corneal thickness.

详细描述

Study Title: Evaluation of different lenticule diameters in myopic astigmatic correction with SMILE procedures Primary Investigator: Dr. Ahmed Sedky (Eye Subspecialty Center, Cairo, Egypt, 18 Elkhalifa Elmamoun Street, Heliopolis, Cairo, Egypt) Co-Investigators: Sherine S Wahba, Maged M Roshdy, Nermeen A Refaat Study Objectives Primary Objective: To study the effect of changing the lenticule diameter on the safety and effectiveness of myopic astigmatism correction with the SMILE procedure.

Secondary Objective: To compare other outcomes such as visual outcomes including immediate visual acuity, contrast sensitivity, and epithelial remodeling.

Participants and Methods:

Study Setting: Eye Subspecialty Center, Cairo, Egypt, 18 Elkhalifa Elmamoun Street, Heliopolis, Cairo, Egypt and Al Watany Eye Hospital, Althawra Street, Cairo, Egypt Study design: Hospital-based, comparative, prospective, interventional contralateral eye study Sample size and randomization: 50 participants fulfilling the inclusion criteria will be enrolled in the study. Their right eyes undergo SMILE procedure using the standard 6.5 mm lenticule diameter and their left eyes undergo SMILE procedure but using a larger lenticule diameter of 7.0 mm.

Ethical issues:

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age groups between 18 and 50 years
  • Myopic astigmatism with up to -10.00 D spherical equivalent (SE) and a minimum astigmatism of -1.0 D and a maximum of -5 D. The astigmatism will be divided into low astigmatism (<0.75 D), moderate astigmatism (1.5- 3 D) and high astigmatism (>3 D).
  • Corrected distance visual acuity (CDVA) of 0.7 or better (decimal)

排除标准

  • Thin corneas (< 490 μm)
  • Proven or suspicious cases of corneal ectatic conditions by corneal tomography
  • Previous ocular surgeries
  • Patients taking systemic steroids, immunosuppressants, oral contraceptives, or antidepressants
  • Pregnant females
  • Corneal scars or any ocular pathology likely to affect visual outcomes

结局指标

主要结局

The safety index of using 7 and 6.5 mm lenticule diameters SMILE to treat myopic astigmatism

时间窗: up to 6 months

The safety index (unitless parameter) is calculated as postoperative CDVA/ preoperative CDVA (both in decimal units).

The efficacy index of using 7 and 6.5 mm lenticule diameters SMILE to treat myopic astigmatism

时间窗: up to 6 months

The efficacy index (unitless parameter) is calculated as postoperative UDVA/ preoperative CDVA (both in decimal units).

次要结局

  • Corneal curvature changes after SMILE procedure using 7 and 6.5 mm lenticule diameters SMILE to treat myopic astigmatism.(up to 6 months)
  • Refractive outcomes of using 7 and 6.5 mm lenticule diameters SMILE to treat myopic astigmatism.(up to 6 months)
  • Visual acuity outcomes of using 7 and 6.5 mm lenticule diameters SMILE to treat myopic astigmatism.(up to 6 months)
  • Contrast sensitivity outcomes of using 7 and 6.5 mm lenticule diameters SMILE to treat myopic astigmatism.(up to 6 months)
  • Corneal structural changes after SMILE procedure using 7 and 6.5 mm lenticule diameters SMILE to treat myopic astigmatism.(up to 6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验